The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $61.23

Today's change+1.11 +1.85%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $61.23

Today's change+1.11 +1.85%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.

Merck & Co Inc crosses above 125-day moving average

Merck & Co Inc closed up sharply Friday, rallying (U.S.)$1.11 or 1.85% to (U.S.)$61.23 and crossing above its 125-day moving average. Over the last five days, shares are unchanged, but have gained 15.92% over the last year to date. This security has outperformed the S&P 500 by 5.57% during the last year.

Key company metrics

  • Open(U.S.) $60.49
  • Previous close(U.S.) $60.12
  • High(U.S.) $61.51
  • Low(U.S.) $60.40
  • Bid / Ask-- / --
  • YTD % change+15.92%
  • Volume10,516,352
  • Average volume (10-day)9,700,514
  • Average volume (1-month)11,241,996
  • Average volume (3-month)10,826,890
  • 52-week range(U.S.) $47.97 to (U.S.) $65.46
  • Beta0.77
  • Trailing P/E31.15×
  • P/E 1 year forward16.22×
  • Forward PEG2.54×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield3.07%
  • Trailing EPS(U.S.) $1.97
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.11%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue10,5369,8449,31210,215
Total other revenue--------
Total revenue10,5369,8449,31210,215
Gross profit7,1636,3325,7876,446
Total cost of revenue3,3733,5123,5253,769
Total operating expense7,6278,3217,6408,496
Selling / general / administrative2,3562,3532,3132,560
Research & development1,6502,0871,6041,780
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)248369198387
Other operating expenses, total--------
Operating income2,9091,5231,6721,719
Interest income (expense), net non-operating-170-171-172-169
Gain (loss) on sale of assets--------
Other--------
Income before tax2,8871,5041,624816
Income after tax2,1881,2091,130982
Income tax, total699295494-166
Net income2,1841,2051,125977
Total adjustments to net income--------
Net income before extra. items2,1841,2051,125977
Minority interest-4-4-5-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,1841,2051,125977
Inc. avail. to common incl. extra. items2,1841,2051,125977
Diluted net income2,1841,2051,125977
Dilution adjustment--------
Diluted weighted average shares2,7862,7892,7952,814
Diluted EPS excluding extraordinary itemsvalue per share0.780.430.400.35
Dividends per sharevalue per share0.460.460.460.46
Diluted normalized EPSvalue per share0.850.540.450.44